Announcements Trials
Browse Landscape

Phase

Phase 2 13Phase 1 4Phase EARLY_PHASE1 1Phase 3 1Phase 1/2 1

Status

Completed 4

Sponsor Class

OTHER 3NETWORK 1

Study Type

Interventional 4

Sponsor

Cancer Type

Breast 28Gynecologic 22Other solid neoplasm 14Tumor-Agnostic 13Genitourinary 12Gastrointestinal 11Thoracic 7Head & Neck 5Sarcoma 4Lymphoid 4Classical hematology 3NET 2Endocrine 2Dermatologic 2Plasma cell 1Other hematologic neoplasm 1Myeloid 1CNS 1

Conditions

Sarcoma 2Sarcoma, Ewing 1Rhabdomyosarcoma 1Gliosarcoma 1Glioblastoma 1Central Nervous System Neoplasms 1Brain Neoplasms 1Bone Neoplasms 1

Interventions

Temozolomide 62Cyclophosphamide 59Radiotherapy 47Doxorubicin 36Filgrastim 26Irinotecan 24Radiation 23Gemcitabine 23fludarabine 22Magnetic Resonance Spectroscopy 20Imatinib Mesylate 19Etoposide 18pembrolizumab 16Cisplatin 15Carboplatin 15Biopsy 15Bevacizumab 15Specimen Handling 14fludarabine phosphate 12Nivolumab 12Leucovorin 12Ipilimumab 12Granulocyte Colony-Stimulating Factor 12Chemotherapy, Adjuvant 12pazopanib 11Vincristine 11Ifosfamide 11Melphalan 10Erlotinib Hydrochloride 10Docetaxel 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 1 × olaparib × Sarcoma × Clear all
NCT02787642 2026-02-25

RADIOSARP

Institut Bergonié

Phase 1 Completed
41 enrolled 15 charts
Sarcoma

Sarcoma

NCT01858168 2025-12-19

Phase I Study of Olaparib and Temozolomide for Ewings Sarcoma or Rhabdoomyosarcoma

Massachusetts General Hospital

Phase 1 Completed
49 enrolled
Sarcoma

Rhabdomyosarcoma, Sarcoma, Ewing

NCT02398058 2021-04-14

TOMAS

Italian Sarcoma Group

Phase 1 Completed
50 enrolled
Sarcoma

Bone Neoplasms, Sarcoma

NCT01390571 2018-02-05

Olaparib and Temozolomide in Treating Patients With Relapsed Glioblastoma

Cancer Research UK

Phase 1 Completed
34 enrolled
CNSSarcoma

Brain Neoplasms, Glioblastoma, Central Nervous System Neoplasms, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡